e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Paediatric epidemiology: infection, prematurity and congenital abnormalities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Etiology and clinical outcome of pediatric non-cystic fibrosis bronchiectasis
S. Castanhinha, T. Bandeira, T. Nunes, L. Pereira (Lisbon, Portugal)
Source:
Annual Congress 2010 - Paediatric epidemiology: infection, prematurity and congenital abnormalities
Session:
Paediatric epidemiology: infection, prematurity and congenital abnormalities
Session type:
Thematic Poster Session
Number:
2713
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Castanhinha, T. Bandeira, T. Nunes, L. Pereira (Lisbon, Portugal). Etiology and clinical outcome of pediatric non-cystic fibrosis bronchiectasis. Eur Respir J 2010; 36: Suppl. 54, 2713
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Diagnosis and management of non-cystic fibrosis bronchiectasis in children
Source: International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment
Year: 2018
Management and prevention of non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – PG9 Lower respiratory tract infection in children
Year: 2015
Changing characteristics of childhood non-cystic fibrosis bronchiectasis
Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection
Year: 2011
Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020
Exacerbations in non cystic fibrosis bronchiectasis: clinical features and investigations
Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood
Year: 2009
Diagnosing bronchiectasis and cystic fibrosis
Source: International Congress 2018 – ME8 Diagnosing bronchiectasis and cystic fibrosis
Year: 2018
Demographics and characteristics of antibiotic use in non-cystic fibrosis bronchiectasis patients
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016
The prevalence of non-cystic fibrosis bronchiectasis in a pediatric respiratory unit
Source: International Congress 2018 – Orphan diseases in children
Year: 2018
Non-cystic fibrosis bronchiectasis in children
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021
Non-cystic fibrosis bronchiectasis in children
Source: Annual Congress 2005 - MP11 - Non-cystic fibrosis bronchiectasis in children
Year: 2005
HRCT features in patients with severe asthma and non-cystic fibrosis bronchiectasis.
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020
Patients hospitalised with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Role of non-cystic fibrosis bronchiectasis in hospitalized patients with acute exacerbation of COPD
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017
Clinical and functional profile of patients with non-cystic fibrosis bronchiectasis according to the presence of chronic bronchial infection
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Pneumothorax in paediatric cystic fibrosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 620s
Year: 2005
The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2019; 83: 158-172
Year: 2019
Bronchiectasis: epidemiology and causes
Source: Eur Respir Mon 2011; 52: 1-10
Year: 2011
Multiple faces of non-cystic fibrosis bronchiectasis: defining etiology and disease severity
Source: International Congress 2017 – Management of asthma in different situations
Year: 2017
Quality of life in patients with non-cystic fibrosis bronchiectasis based on radiologic findings
Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept